EMC
47
11
DHR
66
2
PNW
53
-3
TXN
50
2
JBHT
65
2
WDC
70
2
CRM
70
18
ADT
50
2
STZ
42
-2
HIG
68
5
UHS
55
3
CNP
49
-6
CI
48
-4
ALL
56
2
KLAC
72
2
VTR
67
-3
MHK
43
-2
CAG
41
-5
SO
46
-5
OXY
40
2
EMC
47
11
DHR
66
2
PNW
53
-3
TXN
50
2
JBHT
65
2
WDC
70
2
CRM
70
18
ADT
50
2
STZ
42
-2
HIG
68
5
UHS
55
3
CNP
49
-6
CI
48
-4
ALL
56
2
KLAC
72
2
VTR
67
-3
MHK
43
-2
CAG
41
-5
SO
46
-5
OXY
40
2
Financhill
Back

UroGen Pharma Ltd. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
21

URGN
UroGen Pharma Ltd.

Last Price:
$22.77
Seasonality Move:
-2.48%

7 Day Trial

ALL ACCESS PASS

$ 7

UroGen Pharma Ltd. Stock Forecast

  • Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.3% based on the past 8 years of stock performance.
  • UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is UroGen Pharma Ltd. Stock Undervalued?
    The current UroGen Pharma Ltd. [URGN] share price is $22.80. The Score for URGN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Ltd. Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma Ltd. has on average historically risen by 9.3% based on the past 8 years of stock performance.

UroGen Pharma Ltd. Stock Rating

Sell
21
UroGen Pharma Ltd. (URGN) is a Sell

Is UroGen Pharma Ltd. overpriced?

  • UroGen Pharma Ltd. has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

UroGen Pharma Ltd. Stock Price History

Is URGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URGN is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
30.00
52-Week Low:
3.42

Prediction Charts

Market Cap:
1.1B
Price in USD:
22.80
Volume:
540.8K
Beta:
1.30

Technical Analysis

SMA50:
22.09
SMA100:
20.46
SMA200:
15.80
52-Wk Change:
112.89%

Stock Predictions

  • Is UroGen Pharma Ltd. stock public?
    Yes, UroGen Pharma Ltd. is a publicly traded company.
  • What is the UroGen Pharma Ltd. stock quote today?
    The UroGen Pharma Ltd. stock price is 22.80 USD today.
  • How to buy UroGen Pharma Ltd. stock online?
    You can buy UroGen Pharma Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 28.45 24.38 28.69 24.00
Dec-3 24.50 24.35 25.83 24.27
Dec-4 24.42 24.28 24.92 23.92
Dec-5 23.77 22.98 24.65 22.51
Dec-8 23.37 23.08 23.74 22.82
Dec-9 23.15 22.70 23.56 22.67
Dec-10 22.74 22.19 23.24 22.11
Dec-11 22.35 22.36 22.62 21.74
Dec-12 22.38 21.80 22.66 21.78
Dec-15 21.90 22.85 22.92 21.40
Dec-16 22.88 23.47 24.71 22.88
Dec-17 23.44 22.62 23.80 22.42
Dec-18 22.72 21.72 22.93 21.62
Dec-19 21.92 22.80 23.20 21.72

UroGen Pharma Ltd. Earnings

UroGen Pharma Ltd. Earnings Report: Per Share UroGen Pharma Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Ltd. Forecast Revenue Growth

UroGen Pharma Ltd. Stock Analysis: Historical quarterly revenues per share for UroGen Pharma Ltd. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.00 per share, and an increase next year of $2.53 per share.

* UroGen Pharma Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.